{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:59:13Z","timestamp":1777503553373,"version":"3.51.4"},"reference-count":34,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2022,6,12]],"date-time":"2022-06-12T00:00:00Z","timestamp":1654992000000},"content-version":"unspecified","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"crossref","award":["17\/136\/13"],"award-info":[{"award-number":["17\/136\/13"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2022,5,9]]},"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Sepsis is a common, potentially life-threatening complication of infection. The optimal treatment for sepsis includes prompt antibiotics and intravenous fluids, facilitated by its early and accurate recognition. Currently, clinicians identify and assess severity of suspected sepsis using validated clinical scoring systems. In England, the National Early Warning Score 2 (NEWS2) has been mandated across all National Health Service (NHS) trusts and ambulance organisations. Like many clinical scoring systems, NEWS2 should not be used without clinical judgement to determine either the level of acuity or a diagnosis. Despite this, there is a tendency to overemphasise the score in isolation in patients with suspected infection, leading to the overprescription of antibiotics and potentially treatment-related complications and rising antimicrobial resistance. The biomarker procalcitonin (PCT) has been shown to be useful in specific circumstances to support appropriate antibiotics prescribing by identifying bacterial infection. PCT is not routinely used in the care of undifferentiated patients presenting to emergency departments (EDs), and the evidence base of its optimal usage is poor. The PROcalcitonin and NEWS2 evaluation for Timely identification of sepsis and Optimal (PRONTO) study is a randomised controlled trial (RCT) in adults with suspected sepsis presenting to the ED to compare standard clinical management based on NEWS2 scoring plus PCT-guided risk assessment with standard clinical management based on NEWS2 scoring alone and compare if this approach reduces prescriptions of antibiotics without increasing mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>PRONTO is a parallel two-arm open-label individually RCT set in up to 20 NHS EDs in the UK with a target sample size of 7676 participants. Participants will be randomised in a ratio of 1:1 to standard clinical management based on NEWS2 scoring or standard clinical management based on NEWS2 scoring plus PCT-guided risk assessment. We will compare whether the addition of PCT measurement to NEWS2 scoring can lead to a reduction in intravenous antibiotic initiation in ED patients managed as suspected sepsis, with at least no increase in 28-day mortality compared with NEWS2 scoring alone (in conjunction with local standard care pathways). PRONTO has two coprimary endpoints: initiation of intravenous antibiotics at 3\u2009hours (superiority comparison) and 28-day mortality (non-inferiority comparison). The study has an internal pilot phase and group-sequential stopping rules for effectiveness and futility\/safety, as well as a qualitative substudy and a health economic evaluation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The trial protocol was approved by the Health Research Authority (HRA) and NHS Research Ethics Committee (Wales REC 2, reference 20\/WA\/0058). In England and Wales, the law allows the use of deferred consent in approved research situations (including ED studies) where the time dependent nature of intervention would not allow true informed consent to be obtained. PRONTO has approval for a deferred consent process to be used. Findings will be disseminated through peer-reviewed journals and presented at scientific conferences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"isrctn\" xlink:href=\"ISRCTN54006056\">ISRCTN54006056<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2022-063424","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T11:38:25Z","timestamp":1655120305000},"page":"e063424","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":15,"title":["PROcalcitonin and NEWS2 evaluation for Timely identification of sepsis and Optimal use of antibiotics in the emergency department (PRONTO): protocol for a multicentre, open-label, randomised controlled trial"],"prefix":"10.1136","volume":"12","clinical-trial-number":[{"clinical-trial-number":"isrctn54006056","registry":"10.18810\/isrctn"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2844-6878","authenticated-orcid":false,"given":"Joanne","family":"Euden","sequence":"first","affiliation":[{"name":"Centre for Trials Research, Cardiff University, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7716-2786","authenticated-orcid":false,"given":"Emma","family":"Thomas-Jones","sequence":"additional","affiliation":[{"name":"Centre for Trials Research, Cardiff University, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0701-8364","authenticated-orcid":false,"given":"Stephen","family":"Aston","sequence":"additional","affiliation":[{"name":"Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8263-7130","authenticated-orcid":false,"given":"Lucy","family":"Brookes-Howell","sequence":"additional","affiliation":[{"name":"Centre for Trials Research, Cardiff University, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Carman","sequence":"additional","affiliation":[{"name":"PPI representative, Lancashire, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8357-7726","authenticated-orcid":false,"given":"Enitan","family":"Carrol","sequence":"additional","affiliation":[{"name":"Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Gilbert","sequence":"additional","affiliation":[{"name":"Centre for Trials Research, Cardiff University, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5096-0240","authenticated-orcid":false,"given":"Philip","family":"Howard","sequence":"additional","affiliation":[{"name":"School of Healthcare, Faculty of Medicine and Health, University of Leeds, Leeds, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5268-8631","authenticated-orcid":false,"given":"Kerenza","family":"Hood","sequence":"additional","affiliation":[{"name":"Centre for Trials Research, Cardiff University, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6026-2246","authenticated-orcid":false,"given":"Matthew","family":"Inada-Kim","sequence":"additional","affiliation":[{"name":"Acute Medicine, Hampshire Hospitals NHS Foundation Trust, Winchester, UK"},{"name":"NHS England and NHS Improvement, University of Southampton, Southampton, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6811-1124","authenticated-orcid":false,"given":"Martin","family":"Llewelyn","sequence":"additional","affiliation":[{"name":"Infectious Diseases and Therapeutics, Brighton and Sussex Medical School, Brighton, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0903-9046","authenticated-orcid":false,"given":"Fiona","family":"McGill","sequence":"additional","affiliation":[{"name":"Departments of Infectious Diseases and Medical Microbiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1973-8286","authenticated-orcid":false,"given":"Sarah","family":"Milosevic","sequence":"additional","affiliation":[{"name":"Centre for Trials Research, Cardiff University, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8639-5191","authenticated-orcid":false,"given":"Louis Wihelmus","family":"Niessen","sequence":"additional","affiliation":[{"name":"Health Economics, Liverpool School of Tropical Medicine, Liverpool, UK"},{"name":"School of Public Health, Johns Hopkins, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4750-1235","authenticated-orcid":false,"given":"Emmanuel","family":"Nsutebu","sequence":"additional","affiliation":[{"name":"Tropical and Infectious Diseases Division, Sheikh Shakhbout Medical City, Abu Dabi, UAE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8274-9696","authenticated-orcid":false,"given":"Philip","family":"Pallmann","sequence":"additional","affiliation":[{"name":"Centre for Trials Research, Cardiff University, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Acute Medical Unit, Portsmouth Hospitals NHS Trust, Portsmouth, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Taylor-Robinson","sequence":"additional","affiliation":[{"name":"Department of Public Health, Policy and Systems, University of Liverpool, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3408-8798","authenticated-orcid":false,"given":"Ingeborg","family":"Welters","sequence":"additional","affiliation":[{"name":"Institute for Life Course and Medical Sciences, University of Liverpool, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3215-9625","authenticated-orcid":false,"given":"Stacy","family":"Todd","sequence":"additional","affiliation":[{"name":"Tropical and Infectious Disease Unit, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4814-8293","authenticated-orcid":false,"given":"Neil","family":"French","sequence":"additional","affiliation":[{"name":"Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK"},{"name":"Tropical and Infectious Disease Unit, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,6,13]]},"reference":[{"key":"2025121511410014000_12.6.e063424.1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287"},{"key":"2025121511410014000_12.6.e063424.2","unstructured":"NICE Sepsis Guide Development Group . Sepsis: recognition, diagnosis and early management, NICE guideline [NG51]. Available: Last Update. www.nice.org.uk\/guidance\/ng51."},{"key":"2025121511410014000_12.6.e063424.3","doi-asserted-by":"publisher","DOI":"10.1136\/emermed-2012-202186"},{"key":"2025121511410014000_12.6.e063424.4","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1017\/ice.2017.139","article-title":"A role for antimicrobial stewardship in clinical sepsis pathways: a prospective interventional study","volume":"38","author":"Burston","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2025121511410014000_12.6.e063424.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32483-3"},{"key":"2025121511410014000_12.6.e063424.6","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-015-1035-1","article-title":"Likelihood of infection in patients with presumed sepsis at the time of intensive care unit admission: a cohort study","volume":"19","author":"Klein Klouwenberg","year":"2015","journal-title":"Crit Care"},{"key":"2025121511410014000_12.6.e063424.7","unstructured":"O'Neill J . Tackling drug-resistant infections globally: final report and recommendations. London: The review on antimicrobial resistance, 2016."},{"key":"2025121511410014000_12.6.e063424.8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240206","article-title":"Characterisation of 22445 patients attending UK emergency departments with suspected COVID-19 infection: observational cohort study","volume":"15","author":"Goodacre","year":"2020","journal-title":"PLoS One"},{"key":"2025121511410014000_12.6.e063424.9","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30592-3"},{"key":"2025121511410014000_12.6.e063424.10","doi-asserted-by":"crossref","DOI":"10.1017\/S095026882000179X","article-title":"Risk factors of severe cases with COVID-19: a meta-analysis","volume":"148","author":"Ou","year":"2020","journal-title":"Epidemiol Infect"},{"key":"2025121511410014000_12.6.e063424.11","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2020-0471-SA"},{"key":"2025121511410014000_12.6.e063424.12","unstructured":"RCo P . National early warning score (news) 2. Available: https:\/\/www.rcplondon.ac.uk\/projects\/outputs\/national-early-warning-score-news-2 [Accessed Last Update December 2017]."},{"key":"2025121511410014000_12.6.e063424.13","doi-asserted-by":"crossref","unstructured":"Graham CA , Hung KKC , Leung LY . Sirs and NEWS2 to predict 60-Day mortality in the emergency department: prospective study. Am J Respir Crit Care Med 2019.doi:10.1164\/ajrccm-conference.2019.199.1_MeetingAbstracts.A7157","DOI":"10.1164\/ajrccm-conference.2019.199.1_MeetingAbstracts.A7157"},{"key":"2025121511410014000_12.6.e063424.14","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8081128","article-title":"NEWS2 is superior to qSOFA in detecting sepsis with organ dysfunction in the emergency department","volume":"8","author":"Mellhammar","year":"2019","journal-title":"J Clin Med"},{"key":"2025121511410014000_12.6.e063424.15","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201604-0854OC"},{"key":"2025121511410014000_12.6.e063424.16","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000003359"},{"key":"2025121511410014000_12.6.e063424.17","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1097\/CCM.0000000000005357","article-title":"Executive summary: surviving sepsis campaign: international guidelines for the management of sepsis and septic shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med"},{"key":"2025121511410014000_12.6.e063424.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.07.033"},{"key":"2025121511410014000_12.6.e063424.19","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.cmi.2020.07.016","article-title":"Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis","volume":"26","author":"Langford","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"2025121511410014000_12.6.e063424.20","article-title":"Features of 20\u2009133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study","volume":"369","author":"Docherty","year":"2020","journal-title":"BMJ"},{"key":"2025121511410014000_12.6.e063424.21","doi-asserted-by":"crossref","DOI":"10.1186\/s13049-020-00764-3","article-title":"National Early Warning Score 2 (NEWS2) on admission predicts severe disease and in-hospital mortality from Covid-19 - a prospective cohort study","volume":"28","author":"Myrstad","year":"2020","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"2025121511410014000_12.6.e063424.22","unstructured":"NICE . Procalcitonin testing for diagnosing and monitoring sepsis (ADVIA Centaur BRAHMS PCT assay, BRAHMS PCT Sensitive Kryptor assay, Elecsys BRAHMS PCT assay, LIAISON BRAHMS PCT assay and VIDAS BRAHMS PCT assay): Daignostic Guidance [DG18]; 2015."},{"key":"2025121511410014000_12.6.e063424.23","doi-asserted-by":"publisher","DOI":"10.3310\/hta19880"},{"key":"2025121511410014000_12.6.e063424.24","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics10111425","article-title":"Procalcitonin increase is associated with the development of critical care-acquired infections in COVID-19 ARDS","volume":"10","author":"Richards","year":"2021","journal-title":"Antibiotics"},{"key":"2025121511410014000_12.6.e063424.25","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/cid\/ciz545","article-title":"Procalcitonin to distinguish viral from bacterial pneumonia: a systematic review and meta-analysis","volume":"70","author":"Kamat","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025121511410014000_12.6.e063424.26","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.330.7495.843","article-title":"Treatment allocation by minimisation","volume":"330","author":"Altman","year":"2005","journal-title":"BMJ"},{"key":"2025121511410014000_12.6.e063424.27","unstructured":"NIHR . Sepsis: Quality standard [QS161]. Available: https:\/\/www.nice.org.uk\/guidance\/qs161"},{"key":"2025121511410014000_12.6.e063424.28","unstructured":"Medicines for human use (Clinical trials) Amendment Regulations (SISi 2006\/1928) 2006."},{"key":"2025121511410014000_12.6.e063424.29","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1473-3099(18)30289-5","article-title":"Use of co-primary outcomes for trials of antimicrobial stewardship interventions","volume":"18","author":"Gillespie","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2025121511410014000_12.6.e063424.30","doi-asserted-by":"publisher","DOI":"10.1136\/emermed-2017-207120"},{"key":"2025121511410014000_12.6.e063424.31","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/19466315.2014.1003090","article-title":"Group-Sequential strategies in clinical trials with multiple co-primary outcomes","volume":"7","author":"Hamasaki","year":"2015","journal-title":"Stat Biopharm Res"},{"key":"2025121511410014000_12.6.e063424.32","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/pst.1716","article-title":"Practical guide to sample size calculations: non-inferiority and equivalence trials","volume":"15","author":"Flight","year":"2016","journal-title":"Pharm Stat"},{"key":"2025121511410014000_12.6.e063424.33","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-020-4070-4","article-title":"Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation","volume":"21","author":"Quartagno","year":"2020","journal-title":"Trials"},{"key":"2025121511410014000_12.6.e063424.34","unstructured":"Animated S . Optimising antibiotic use in sepsis: PRONTO trial. Available: https:\/\/www.youtube.com\/watch?v=H3x-rNVlwJI"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2022-063424","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:41:14Z","timestamp":1765827674000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2022-063424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":34,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6,13]]},"published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10.1136\/bmjopen-2022-063424"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2022-063424","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6]]}}}